JJ
HLTH

Johnson & Johnson’s Cue Health Inc. Common Stock HLTH Stock Holding History

Johnson & Johnson’s Portfolio HLTH Stock Details HLTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-5,548,864
Closed -$2.45M – 25
2023
Q3 		$2.45M Hold
5,548,864
– – 0.9% 14
2023
Q2 		$2.05M Hold
5,548,864
– – 0.64% 14
2023
Q1 		$10.1M Hold
5,548,864
– – 3.29% 9
2022
Q4 		$11.5M Hold
5,548,864
– – 3.34% 9
2022
Q3 		$16.7M Hold
5,548,864
– – 4.91% 8
2022
Q2 		$17.8M Hold
5,548,864
– – 4.54% 9
2022
Q1 		$35.8M Hold
5,548,864
– – 6.77% 6
2021
Q4 		$74.4M Hold
5,548,864
– – 8.47% 5
2021
Q3 		$65.5M Buy
+5,548,864
New +$87.4M 5.75% 5

Other funds holding HLTH

TC
Tarsadia Capital New York $5.64M AUM 15.7% 1-Year Est. Return
OC
Oakmont Corp Los Angeles, California $526M AUM 7.52% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
JPC
Jabodon PT Co Reno, Nevada $1.02B AUM 22.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Johnson & Johnson's HLTH Position: Q4 2023 in Review

Johnson & Johnson sold out of Cue Health Inc. Common Stock (HLTH) in Q4 2023, closing a stake of 5,548,864 shares — an estimated $2.45M sold.

Johnson & Johnson first reported a position in HLTH in Q3 2021 and held it in 9 quarters. The position peaked at $74.4M in Q4 2021. 63 funds tracked by Wall St. Rank hold HLTH as of Q4 2023.

  • Johnson & Johnson reported no remaining Cue Health Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Johnson & Johnson sold 5,548,864 Cue Health Inc. Common Stock shares in Q4 2023, an estimated $2.45M.
  • Johnson & Johnson first reported a position in Cue Health Inc. Common Stock in Q3 2021 and held it in 9 quarters.
  • Johnson & Johnson's Cue Health Inc. Common Stock position peaked at $74.4M in Q4 2021.
  • 63 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q4 2023.

Based on Johnson & Johnson's 13F filing for Q4 2023, filed 14 Feb 2024.